Mitochondrial superoxide dismutases-signals of distinction

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 2, 2011, Pages 181-190

  Miriyala, Sumitra ^a   Holley, Aaron K ^a   St Clair, Daret K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptotic pathways; MnSOD; mtDNA; Oxidative modification; Oxidative stress; Redox signaling; Retrograde signaling; TOR signaling

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE;

AGING; ARTICLE; CELL DEATH; CELL ENERGY; CELL SURVIVAL; DRUG TARGETING; HUMAN; METABOLIC DISORDER; NEOPLASM; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION; ENZYMOLOGY; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; REVIEW;

HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 79953795697     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152011795255920     Document Type: Article

References (134)

1. Brown, D. I.; Griendling, K. K., Nox proteins in signal transduction. Free Radic. Biol. Med., 2009, 47(9), 1239-1253.
2. Gillespie, M. N.; Pastukh, V.; Ruchko, M. V., Oxidative DNA modifications in hypoxic signaling. Ann. N. Y. Acad. Sci., 2009, 1177, 140-150.
3. Andersen, J. K., Oxidative stress in neurodegeneration: cause or consequence? Nat. Med., 2004, 10 Suppl, S18-25.
4. Fridovich, I., Superoxide radical and superoxide dismutases. Annu. Rev. Biochem., 1995, 64, 97-112.
5. Flint, D. H.; Tuminello, J. F.; Emptage, M. H., The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J. Biol. Chem., 1993, 268(30), 22369-22376.
6. Zelko, I. N.; Mariani, T. J.; Folz, R. J., Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med., 2002, 33(3), 337-349.
7. McCord, J. M.; Keele, B. B., Jr.; Fridovich, I., An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A., 1971, 68(5), 1024-1027.
8. Touati, D., The molecular genetics of superoxide dismutase in E. coli. An approach to understanding the biological role and regulation of SODS in relation to other elements of the defence system against oxygen toxicity. Free Radic. Res. Commun., 1989, 8(1), 1-9.
9. Gregory, E. M.; Fridovich, I., Oxygen toxicity and the superoxide dismutase. J. Bacteriol., 1973, 114(3), 1193-1197.
10. Li, Y.; Huang, T. T.; Carlson, E. J.; Melov, S.; Ursell, P. C.; Olson, J. L.; Noble, L. J.; Yoshimura, M. P.; Berger, C.; Chan, P. H.; Wallace, D. C.; Epstein, C. J., Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet., 1995, 11(4), 376-381.
11. Van Remmen, H.; Ikeno, Y.; Hamilton, M.; Pahlavani, M.; Wolf, N.; Thorpe, S. R.; Alderson, N. L.; Baynes, J. W.; Epstein, C. J.; Huang, T. T.; Nelson, J.; Strong, R.; Richardson, A., Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics, 2003, 16(1), 29-37.
12. Zhang, Y.; Zhang, H. M.; Shi, Y.; Lustgarten, M.; Li, Y.; Qi, W.; Zhang, B. X.; Van Remmen, H., Loss of manganese superoxide dismutase leads to abnormal growth and signal transduction in mouse embryonic fibroblasts. Free Radic. Biol. Med., 2010, 49(8), 1255-1262.
13. Xu, Y.; Krishnan, A.; Wan, X. S.; Majima, H.; Yeh, C. C.; Ludewig, G.; Kasarskis, E. J.; St Clair, D. K., Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene, 1999, 18(1), 93-102.
14. Melov, S.; Schneider, J. A.; Day, B. J.; Hinerfeld, D.; Coskun, P.; Mirra, S. S.; Crapo, J. D.; Wallace, D. C., A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet., 1998, 18(2), 159-163.
15. Jones, P. L.; Ping, D.; Boss, J. M., Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB. Mol. Cell. Biol., 1997, 17(12), 6970-6981.
16. Richter, C.; Gogvadze, V.; Laffranchi, R.; Schlapbach, R.; Schweizer, M.; Suter, M.; Walter, P.; Yaffee, M., Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta, 1995, 1271(1), 67-74.
17. Trump, B. F.; Berezesky, I. K., The role of cytosolic Ca2+ in cell injury, necrosis and apoptosis. Curr. Opin. Cell Biol., 1992, 4(2), 227-232.
18. Aagaard-Tillery, K. M.; Jelinek, D. F., Differential activation of a calcium-dependent endonuclease in human B lymphocytes. Role in ionomycin-induced apoptosis. J. Immunol., 1995, 155(7), 3297-3307.
19. Thanos, D.; Maniatis, T., NF-kappa B: a lesson in family values. Cell, 1995, 80(4), 529-32.
20. Baeuerle, P. A.; Henkel, T., Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 1994, 12, 141-179.
21. Los, M.; Droge, W.; Stricker, K.; Baeuerle, P. A.; Schulze-Osthoff, K., Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur. J. Immunol., 1995, 25(1), 159-165.
22. Los, M.; Schenk, H.; Hexel, K.; Baeuerle, P. A.; Droge, W.; Schulze-Osthoff, K., IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J., 1995, 14(15), 3731-3740.
23. Legrand-Poels, S.; Bours, V.; Piret, B.; Pflaum, M.; Epe, B.; Rentier, B.; Piette, J., Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damages. J. Biol. Chem., 1995, 270(12), 6925-6934.
24. Devary, Y.; Gottlieb, R. A.; Lau, L. F.; Karin, M., Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol., 1991, 11(5), 2804-28011.
25. Nose, K.; Shibanuma, M.; Kikuchi, K.; Kageyama, H.; Sakiyama, S.; Kuroki, T., Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem., 1991, 201(1), 99-106.
26. Lo, Y. Y.; Cruz, T. F., Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem., 1995, 270(20), 11727-11730.
27. Puri, P. L.; Avantaggiati, M. L.; Burgio, V. L.; Chirillo, P.; Collepardo, D.; Natoli, G.; Balsano, C.; Levrero, M., Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cells. Ann. N. Y. Acad. Sci., 1995, 752, 394-405.
28. Datta, R.; Hallahan, D. E.; Kharbanda, S. M.; Rubin, E.; Sherman, M. L.; Huberman, E.; Weichselbaum, R. R.; Kufe, D. W., Involvement of reactive oxygen intermediates in the induction of cjun gene transcription by ionizing radiation. Biochemistry (Mosc). 1992, 31(35), 8300-8306.
29. Janssen, Y. M.; Heintz, N. H.; Mossman, B. T., Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells. Cancer Res., 1995, 55(10), 2085-2089.
30. Galter, D.; Mihm, S.; Droge, W., Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. Eur. J. Biochem., 1994, 221(2), 639-648.
31. Stauble, B.; Boscoboinik, D.; Tasinato, A.; Azzi, A., Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. Eur. J. Biochem., 1994, 226(2), 393-402.
32. Amstad, P. A.; Krupitza, G.; Cerutti, P. A., Mechanism of c-fos induction by active oxygen. Cancer Res., 1992, 52(14), 3952-3960.
33. Pahl, H. L.; Baeuerle, P. A., Oxygen and the control of gene expression. Bioessays, 1994, 16(7), 497-502.
34. Kirkpatrick, D. L.; Ehrmantraut, G.; Stettner, S.; Kunkel, M.; Powis, G., Redox active disulfides: the thioredoxin system as a drug target. Oncol. Res., 1997, 9(6-7), 351-356.
35. Hirota, K.; Matsui, M.; Murata, M.; Takashima, Y.; Cheng, F. S.; Itoh, T.; Fukuda, K.; Yodoi, J., Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun., 2000, 274(1), 177-182.
36. Wei, S. J.; Botero, A.; Hirota, K.; Bradbury, C. M.; Markovina, S.; Laszlo, A.; Spitz, D. R.; Goswami, P. C.; Yodoi, J.; Gius, D., Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res., 2000, 60(23), 6688-6695.
37. Visner, G. A.; Dougall, W. C.; Wilson, J. M.; Burr, I. A.; Nick, H. S., Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J. Biol. Chem., 1990, 265(5), 2856-2864.
38. Lee, T. H.; Lee, G. W.; Ziff, E. B.; Vilcek, J., Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell. Biol., 1990, 10(5), 1982-1988.
39. Jia, Y.; Rothermel, B.; Thornton, J.; Butow, R. A., A basic helixloop-helix-leucine zipper transcription complex in yeast functions in a signaling pathway from mitochondria to the nucleus. Mol. Cell. Biol., 1997, 17(3), 1110-1117.
40. Liao, X.; Butow, R. A., RTG1 and RTG2: two yeast genes required for a novel path of communication from mitochondria to the nucleus. Cell, 1993, 72(1), 61-71.
41. Sekito, T.; Thornton, J.; Butow, R. A., Mitochondria-to-nuclear signaling is regulated by the subcellular localization of the transcription factors Rtg1p and Rtg3p. Mol. Biol. Cell, 2000, 11(6), 2103-2115.
42. Green, D. R.; Kroemer, G., The pathophysiology of mitochondrial cell death. Science, 2004, 305(5684), 626-629.
43. Cory, S.; Huang, D. C.; Adams, J. M., The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 2003, 22(53), 8590-8607.
44. Heckman, C. A.; Mehew, J. W.; Boxer, L. M., NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. Oncogene, 2002, 21(24), 3898-3908.
45. Karin, M.; Lin, A., NF-kappaB at the crossroads of life and death. Nat Immunol, 2002, 3(3), 221-227.
46. Grimm, S.; Bauer, M. K.; Baeuerle, P. A.; Schulze-Osthoff, K., Bcl-2 down-regulates the activity of transcription factor NFkappaB induced upon apoptosis. J. Cell Biol., 1996, 134(1), 13-23.
47. Chou, J. J.; Matsuo, H.; Duan, H.; Wagner, G., Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell, 1998, 94(2), 171-180.
48. Susin, S. A.; Daugas, E.; Ravagnan, L.; Samejima, K.; Zamzami, N.; Loeffler, M.; Costantini, P.; Ferri, K. F.; Irinopoulou, T.; Prevost, M. C.; Brothers, G.; Mak, T. W.; Penninger, J.; Earnshaw, W. C.; Kroemer, G., Two distinct pathways leading to nuclear apoptosis. J. Exp. Med., 2000, 192(4), 571-580.
49. Li, L. Y.; Luo, X.; Wang, X., Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 2001, 412(6842), 95-99.
50. Susin, S. A.; Zamzami, N.; Castedo, M.; Hirsch, T.; Marchetti, P.; Macho, A.; Daugas, E.; Geuskens, M.; Kroemer, G., Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med., 1996, 184(4), 1331-1341.
51. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Brenner, C.; Larochette, N.; Prevost, M. C.; Alzari, P. M.; Kroemer, G., Mitochondrial release of caspase-2 and-9 during the apoptotic process. J. Exp. Med., 1999, 189(2), 381-394.
52. Churbanova, I. Y.; Sevrioukova, I. F., Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor. J. Biol. Chem., 2008, 283(9), 5622-5631.
53. Norberg, E.; Gogvadze, V.; Ott, M.; Horn, M.; Uhlen, P.; Orrenius, S.; Zhivotovsky, B., An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death. Cell Death Differ., 2008, 15(12), 1857-1864.
54. Zhou, M.; Baudry, M., EUK-207, a superoxide dismutase/catalase mimetic, is neuroprotective against oxygen/glucose deprivationinduced neuronal death in cultured hippocampal slices. Brain Res., 2009, 1247, 28-37.
55. Arnoult, D.; Gaume, B.; Karbowski, M.; Sharpe, J. C.; Cecconi, F.; Youle, R. J., Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J, 2003, 22(17), 4385-4399.
56. Wu, M.; Xu, L. G.; Li, X.; Zhai, Z.; Shu, H. B., AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis. J. Biol. Chem., 2002, 277(28), 25617-25623.
57. Ohiro, Y.; Garkavtsev, I.; Kobayashi, S.; Sreekumar, K. R.; Nantz, R.; Higashikubo, B. T.; Duffy, S. L.; Higashikubo, R.; Usheva, A.; Gius, D.; Kley, N.; Horikoshi, N., A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosisinducing factor (AIF). FEBS Lett., 2002, 524(1-3), 163-171.
58. Hockenbery, D. M.; Oltvai, Z. N.; Yin, X. M.; Milliman, C. L.; Korsmeyer, S. J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 1993, 75(2), 241-51.
59. Zhu, W.; Cowie, A.; Wasfy, G. W.; Penn, L. Z.; Leber, B.; Andrews, D. W., Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J., 1996, 15(16), 4130-4141.
60. Wolvetang, E. J.; Johnson, K. L.; Krauer, K.; Ralph, S. J.; Linnane, A. W., Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett., 1994, 339(1-2), 40-44.
61. Robinson, B. H.; Luo, X. P.; Pitkanen, S.; Bratinova, S.; Bourgeois, J.; Lehotay, D. C.; Raha, S., Diagnosis of mitochondrial energy metabolism defects in tissue culture. Induction of MnSOD and bcl-2 in mitochondria from patients with complex I (NADH-CoQ reductase) deficiency. Biofactors, 1998, 7(3), 229-230.
62. Hunter, T., Oncoprotein networks. Cell, 1997, 88(3), 333-346.
63. Allison, S. J.; Milner, J., SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle, 2007, 6(21), 2669-2677.
64. Kim, H. S.; Patel, K.; Muldoon-Jacobs, K.; Bisht, K. S.; Aykin-Burns, N.; Pennington, J. D.; van der Meer, R.; Nguyen, P.; Savage, J.; Owens, K. M.; Vassilopoulos, A.; Ozden, O.; Park, S. H.; Singh, K. K.; Abdulkadir, S. A.; Spitz, D. R.; Deng, C. X.; Gius, D., SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell, 2010, 17(1), 41-52.
65. Yang, H.; Yang, T.; Baur, J. A.; Perez, E.; Matsui, T.; Carmona, J. J.; Lamming, D. W.; Souza-Pinto, N. C.; Bohr, V. A.; Rosenzweig, A.; de Cabo, R.; Sauve, A. A.; Sinclair, D. A., Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell, 2007, 130(6), 1095-1107.
66. Liu, W.; Akhand, A. A.; Kato, M.; Yokoyama, I.; Miyata, T.; Kurokawa, K.; Uchida, K.; Nakashima, I., 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci., 1999, 112(Pt 14), 2409-2417.
67. Liu, W.; Kato, M.; Akhand, A. A.; Hayakawa, A.; Suzuki, H.; Miyata, T.; Kurokawa, K.; Hotta, Y.; Ishikawa, N.; Nakashima, I., 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci., 2000, 113(Pt 4), 635-641.
68. Uchida, K.; Shiraishi, M.; Naito, Y.; Torii, Y.; Nakamura, Y.; Osawa, T., Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem., 1999, 274(4), 2234-2242.
69. Orrenius, S.; Gogvadze, V.; Zhivotovsky, B., Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol., 2007, 47, 143-183.
70. Wong, C. M.; Cheema, A. K.; Zhang, L.; Suzuki, Y. J., Protein carbonylation as a novel mechanism in redox signaling. Circ. Res., 2008, 102(3), 310-318.
71. Weinstein, D. M.; Mihm, M. J.; Bauer, J. A., Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J. Pharmacol. Exp. Ther., 2000, 294(1), 396-401.
72. Aldieri, E.; Bergandi, L.; Riganti, C.; Costamagna, C.; Bosia, A.; Ghigo, D., Doxorubicin induces an increase of nitric oxide synthesis in rat cardiac cells that is inhibited by iron supplementation. Toxicol. Appl. Pharmacol., 2002, 185(2), 85-90.
73. Chaiswing, L.; Cole, M. P.; St Clair, D. K.; Ittarat, W.; Szweda, L. I.; Oberley, T. D., Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury. Toxicol. Pathol., 2004, 32(5), 536-547.
74. Norberg, E.; Gogvadze, V.; Vakifahmetoglu, H.; Orrenius, S.; Zhivotovsky, B., Oxidative modification sensitizes mitochondrial apoptosis-inducing factor to calpain-mediated processing. Free Radic. Biol. Med., 2010, 48(6), 791-797.
75. Norberg, E.; Orrenius, S.; Zhivotovsky, B., Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochem. Biophys. Res. Commun., 2010, 396(1), 95-100.
76. Meng, T. C.; Fukada, T.; Tonks, N. K., Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell, 2002, 9(2), 387-399.
77. Burgoyne, J. R.; Madhani, M.; Cuello, F.; Charles, R. L.; Brennan, J. P.; Schroder, E.; Browning, D. D.; Eaton, P., Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science, 2007, 317(5843), 1393-1397.
78. Oktyabrsky, O. N.; Smirnova, G. V., Redox regulation of cellular functions. Biochemistry (Mosc). 2007, 72(2), 132-145.
79. Klatt, P.; Molina, E. P.; De Lacoba, M. G.; Padilla, C. A.; Martinez-Galesteo, E.; Barcena, J. A.; Lamas, S., Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J., 1999, 13(12), 1481-1490.
80. Pineda-Molina, E.; Klatt, P.; Vazquez, J.; Marina, A.; Garcia de Lacoba, M.; Perez-Sala, D.; Lamas, S., Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry (Mosc). 2001, 40(47), 14134-14142.
81. Liu, B.; Chen, Y.; St Clair, D. K., ROS and p53: a versatile partnership. Free Radic. Biol. Med., 2008, 44(8), 1529-1535.
82. Marshall, H. E.; Merchant, K.; Stamler, J. S., Nitrosation and oxidation in the regulation of gene expression. FASEB J., 2000, 14(13), 1889-1900.
83. Sun, Y.; Oberley, L. W., Redox regulation of transcriptional activators. Free Radic. Biol. Med., 1996, 21(3), 335-348.
84. Rainwater, R.; Parks, D.; Anderson, M. E.; Tegtmeyer, P.; Mann, K., Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol., 1995, 15(7), 3892-3903.
85. Ghezzi, P., Oxidoreduction of protein thiols in redox regulation. Biochem. Soc. Trans., 2005, 33(Pt 6), 1378-1381.
86. Yeo, W. S.; Lee, S. J.; Lee, J. R.; Kim, K. P., Nitrosative protein tyrosine modifications: biochemistry and functional significance. BMB Rep, 2008, 41(3), 194-203.
87. Monteiro, H. P.; Arai, R. J.; Travassos, L. R., Protein tyrosine phosphorylation and protein tyrosine nitration in redox signaling. Antioxid Redox Signal, 2008, 10(5), 843-889.
88. Paulsen, C. E.; Carroll, K. S., Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol, 2010, 5(1), 47-62.
89. Chazotte-Aubert, L.; Hainaut, P.; Ohshima, H., Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem. Biophys. Res. Commun., 2000, 267(2), 609-613.
90. Cobbs, C. S.; Samanta, M.; Harkins, L. E.; Gillespie, G. Y.; Merrick, B. A.; MacMillan-Crow, L. A., Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch. Biochem. Biophys., 2001, 394(2), 167-172.
91. Cobbs, C. S.; Whisenhunt, T. R.; Wesemann, D. R.; Harkins, L. E.; Van Meir, E. G.; Samanta, M., Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res., 2003, 63(24), 8670-8673.
92. Delphin, C.; Cahen, P.; Lawrence, J. J.; Baudier, J., Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding. Eur. J. Biochem., 1994, 223(2), 683-692.
93. Hainaut, P.; Milner, J., Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 1993, 53(19), 4469-4473.
94. Fojta, M.; Kubicarova, T.; Vojtesek, B.; Palecek, E., Effect of p53 protein redox states on binding to supercoiled and linear DNA. J. Biol. Chem., 1999, 274(36), 25749-25755.
95. Fojta, M.; Pivonkova, H.; Brazdova, M.; Nemcova, K.; Palecek, J.; Vojtesek, B., Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function. Eur. J. Biochem., 2004, 271(19), 3865-3876.
96. Sun, X. Z.; Vinci, C.; Makmura, L.; Han, S.; Tran, D.; Nguyen, J.; Hamann, M.; Grazziani, S.; Sheppard, S.; Gutova, M.; Zhou, F.; Thomas, J.; Momand, J., Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid Redox Signal, 2003, 5(5), 655-665.
97. Chene, P., Mutations at position 277 modify the DNA-binding specificity of human p53 in vitro. Biochem. Biophys. Res. Commun., 1999, 263(1), 1-5.
98. Buzek, J.; Latonen, L.; Kurki, S.; Peltonen, K.; Laiho, M., Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. Nucleic Acids Res., 2002, 30(11), 2340-2348.
99. Seo, Y. R.; Kelley, M. R.; Smith, M. L., Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc. Natl. Acad. Sci. U. S. A., 2002, 99(22), 14548-14553.
100. Smith, M. L.; Lancia, J. K.; Mercer, T. I.; Ip, C., Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res., 2004, 24(3a), 1401-1408.
101. Wu, H. H.; Momand, J., Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J. Biol. Chem., 1998, 273(30), 18898-18905.
102. Petitjean, A.; Achatz, M. I.; Borresen-Dale, A. L.; Hainaut, P.; Olivier, M., TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene, 2007, 26(15), 2157-2165.
103. Bolshakov, S.; Walker, C. M.; Strom, S. S.; Selvan, M. S.; Clayman, G. L.; El-Naggar, A.; Lippman, S. M.; Kripke, M. L.; Ananthaswamy, H. N., p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin. Cancer Res., 2003, 9(1), 228-234.
104. Murphy, M. E., Polymorphic variants in the p53 pathway. Cell Death Differ., 2006, 13(6), 916-920.
105. Pietsch, E. C.; Humbey, O.; Murphy, M. E., Polymorphisms in the p53 pathway. Oncogene, 2006, 25(11), 1602-1611.
106. Dumont, P.; Leu, J. I.; Della Pietra, A. C., 3rd; George, D. L.; Murphy, M., The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet., 2003, 33(3), 357-365.
107. Karawajew, L.; Rhein, P.; Czerwony, G.; Ludwig, W. D., Stressinduced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood, 2005, 105(12), 4767-4775.
108. Liu, J.; St Clair, D. K.; Gu, X.; Zhao, Y., Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion. FEBS Lett., 2008, 582(9), 1319-1324.
109. Zhao, Y.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; St Clair, D. K., p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res., 2005, 65(9), 3745-3750.
110. Delsite, R. L.; Rasmussen, L. J.; Rasmussen, A. K.; Kalen, A.; Goswami, P. C.; Singh, K. K., Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. Mutagenesis, 2003, 18(6), 497-503.
111. Park, S. Y.; Chang, I.; Kim, J. Y.; Kang, S. W.; Park, S. H.; Singh, K.; Lee, M. S., Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J. Biol. Chem., 2004, 279(9), 7512-7520.
112. Chandel, N. S.; Vander Heiden, M. G.; Thompson, C. B.; Schumacker, P. T., Redox regulation of p53 during hypoxia. Oncogene, 2000, 19(34), 3840-3848.
113. Duranteau, J.; Chandel, N. S.; Kulisz, A.; Shao, Z.; Schumacker, P. T., Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J. Biol. Chem., 1998, 273(19), 11619-11624.
114. Sansome, C.; Zaika, A.; Marchenko, N. D.; Moll, U. M., Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett., 2001, 488(3), 110-115.
115. Aleshin, A.; Finn, R. S., SRC: a century of science brought to the clinic. Neoplasia, 2010, 12(8), 599-607.
116. Johnson, F. M.; Gallick, G. E., SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy. Anticancer Agents Med. Chem., 2007, 7(6), 651-659.
117. Giannoni, E.; Taddei, M. L.; Chiarugi, P., Src redox regulation: again in the front line. Free Radic. Biol. Med., 2010, 49(4), 516-527.
118. Kemble, D. J.; Sun, G., Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(13), 5070-5075.
119. Akhand, A. A.; Pu, M.; Senga, T.; Kato, M.; Suzuki, H.; Miyata, T.; Hamaguchi, M.; Nakashima, I., Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J. Biol. Chem., 1999, 274(36), 25821-2586.
120. Krasnowska, E. K.; Pittaluga, E.; Brunati, A. M.; Brunelli, R.; Costa, G.; De Spirito, M.; Serafino, A.; Ursini, F.; Parasassi, T., Nacetyl-l-cysteine fosters inactivation and transfer to endolysosomes of c-Src. Free Radic. Biol. Med., 2008, 45(11), 1566-1572.
121. Giannoni, E.; Buricchi, F.; Raugei, G.; Ramponi, G.; Chiarugi, P., Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol., 2005, 25(15), 6391-6403.
122. Cardone, L.; Carlucci, A.; Affaitati, A.; Livigni, A.; DeCristofaro, T.; Garbi, C.; Varrone, S.; Ullrich, A.; Gottesman, M. E.; Avvedimento, E. V.; Feliciello, A., Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signaling. Mol. Cell. Biol., 2004, 24(11), 4613-4626.
123. Itoh, S.; Lemay, S.; Osawa, M.; Che, W.; Duan, Y.; Tompkins, A.; Brookes, P. S.; Sheu, S. S.; Abe, J., Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells. J. Biol. Chem., 2005, 280(28), 26383-26396.
124. Lluis, J. M.; Buricchi, F.; Chiarugi, P.; Morales, A.; Fernandez-Checa, J. C., Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res., 2007, 67(15), 7368-7377.
125. Graham, K. A.; Kulawiec, M.; Owens, K. M.; Li, X.; Desouki, M. M.; Chandra, D.; Singh, K. K., NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther, 2010, 10(3), 223-231.
126. Block, K.; Gorin, Y.; Abboud, H. E., Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(34), 14385-14390.
127. Block, K.; Eid, A.; Griendling, K. K.; Lee, D. Y.; Wittrant, Y.; Gorin, Y., Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem., 2008, 283(35), 24061-24076.
128. Hayashi, T.; Ueno, Y.; Okamoto, T., Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem., 1993, 268(15), 11380-11388.
129. Valle, A.; Kinet, J. P., N-acetyl-L-cysteine inhibits antigenmediated Syk, but not Lyn tyrosine kinase activation in mast cells. FEBS Lett., 1995, 357(1), 41-44.
130. Li, S.; Yan, T.; Yang, J. Q.; Oberley, T. D.; Oberley, L. W., The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res., 2000, 60(14), 3927-3939.
131. Zhang, H. J.; Zhao, W.; Venkataraman, S.; Robbins, M. E.; Buettner, G. R.; Kregel, K. C.; Oberley, L. W., Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J. Biol. Chem., 2002, 277(23), 20919-20926.
132. Kim, K. H.; Rodriguez, A. M.; Carrico, P. M.; Melendez, J. A., Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase. Antioxid. Redox Signal, 2001, 3(3), 361-373.
133. Rodriguez, A. M.; Carrico, P. M.; Mazurkiewicz, J. E.; Melendez, J. A., Mitochondrial or cytosolic catalase reverses the MnSODdependent inhibition of proliferation by enhancing respiratory chain activity, net ATP production, and decreasing the steady state levels of H(2)O(2). Free Radic. Biol. Med., 2000, 29(9), 801-813.
134. Buettner, G. R.; Ng, C. F.; Wang, M.; Rodgers, V. G.; Schafer, F. Q., A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med., 2006, 41(8), 1338-1350.